|
1
|
Yan J and Horng T: Lipid metabolism in
regulation of macrophage functions. Trends Cell Biol. 30:979–989.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wynn TA, Chawla A and Pollard JW:
Macrophage biology in development, homeostasis and disease. Nature.
496:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murray PJ and Wynn TA: Protective and
pathogenic functions of macrophage subsets. Nat Rev Immunol.
11:723–737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murray PJ: Macrophage polarization. Annu
Rev Physiol. 79:541–566. 2017. View Article : Google Scholar
|
|
5
|
Chinnery HR, McMenamin PG and Dando SJ:
Macrophage physiology in the eye. Pflugers Arch. 469:501–515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu F, Shi M, Zheng C, Shen D, Zhu J,
Zheng X and Cui L: The roles of macrophages and microglia in
multiple sclerosis and experimental autoimmune encephalomyelitis. J
Neuroimmunol. 318:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Norden DM, Muccigrosso MM and Godbout JP:
Microglial priming and enhanced reactivity to secondary insult in
aging, and traumatic CNS injury, and neurodegenerative disease.
Neuropharmacology. 96:29–41. 2015. View Article : Google Scholar :
|
|
8
|
Kabba JA, Xu Y, Christian H, Ruan W,
Chenai K, Xiang Y, Zhang L, Saavedra JM and Pang T: Microglia:
Housekeeper of the central nervous system. Cell Mol Neurobiol.
38:53–71. 2018. View Article : Google Scholar
|
|
9
|
Das A, Sinha M, Datta S, Abas M, Chaffee
S, Sen CK and Roy S: Monocyte and macrophage plasticity in tissue
repair and regeneration. Am J Pathol. 185:2596–2606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biswas SK, Chittezhath M, Shalova IN and
Lim JY: Macrophage polarization and plasticity in health and
disease. Immunol Res. 53:11–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Strauss O, Dunbar PR, Bartlett A and
Phillips A: The immunophenotype of antigen presenting cells of the
mononuclear phagocyte system in normal human liver-a systematic
review. J Hepatol. 62:458–468. 2015. View Article : Google Scholar
|
|
12
|
McMurran CE, Jones CA, Fitzgerald DC and
Franklin RJ: CNS remyelination and the innate immune system. Front
Cell Dev Biol. 4:382016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tay TL, Hagemeyer N and Prinz M: The force
awakens: Insights into the origin and formation of microglia. Curr
Opin Neurobiol. 39:30–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Subramaniam SR and Federoff HJ: Targeting
microglial activation states as a therapeutic avenue in Parkinson's
disease. Front Aging Neurosci. 9:1762017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du L, Zhang Y, Chen Y, Zhu J, Yang Y and
Zhang HL: Role of microglia in neurological disorders and their
potentials as a therapeutic target. Mol Neurobiol. 54:7567–7584.
2017. View Article : Google Scholar
|
|
16
|
Jiang HR, Milovanović M, Allan D, Niedbala
W, Besnard AG, Fukada SY, Alves-Filho JC, Togbe D, Goodyear CS,
Linington C, et al: IL-33 attenuates EAE by suppressing IL-17 and
IFN-gamma production and inducing alternatively activated
macrophages. Eur J Immunol. 42:1804–1814. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Butovsky O, Landa G, Kunis G, Ziv Y,
Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S and
Schwartz M: Induction and blockage of oligodendrogenesis by
differently activated microglia in an animal model of multiple
sclerosis. J Clin Invest. 116:905–915. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boche D, Perry VH and Nicoll JA: Review:
Activation patterns of microglia and their identification in the
human brain. Neuropath Appl Neuro. 39:3–18. 2013. View Article : Google Scholar
|
|
19
|
Mills CD: M1 and M2 macrophages: Oracles
of health and disease. Crit Rev Immunol. 32:463–488. 2012.
View Article : Google Scholar
|
|
20
|
Ransohoff RM and Brown MA: Innate immunity
in the central nervous system. J Clin Invest. 122:1164–1171. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ransohoff RM and Perry VH: Microglial
physiology: Unique stimuli, specialized responses. Annu Rev
Immunol. 27:119–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Graeber MB: Changing face of microglia.
Science. 330:783–788. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stout RD, Jiang C, Matta B, Tietzel I,
Watkins SK and Suttles J: Macrophages sequentially change their
functional phenotype in response to changes in microenvironmental
influences. J Immunol. 175:342–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang N, Liang H and Zen K: Molecular
mechanisms that influence the macrophage m1-m2 polarization
balance. Front Immunol. 5:6142014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantovani A, Sica A, Sozzani S, Allavena
P, Vecchi A and Locati M: The chemokine system in diverse forms of
macrophage activation and polarization. Trends Immunol. 25:677–686.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varnum MM and Ikezu T: The classification
of microglial activation phenotypes on neurodegeneration and
regeneration in Alzheimer's disease brain. Arch Immunol Ther Exp
(Warsz). 60:251–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Colton C and Wilcock DM: Assessing
activation states in microglia. CNS Neurol Disord Drug Targets.
9:174–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Henkel JS, Beers DR, Zhao W and Appel SH:
Microglia in ALS: The good, the bad, and the resting. J Neuroimmune
Pharm. 4:389–398. 2009. View Article : Google Scholar
|
|
30
|
Hanisch UK and Kettenmann H: Microglia:
Active sensor and versatile effector cells in the normal and
pathologic brain. Nat Neurosci. 10:1387–1394. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang LX, Zhang SX, Wu HJ, Rong XL and Guo
J: M2b macrophage polarization and its roles in diseases. J Leukoc
Biol. 106:345–358. 2019. View Article : Google Scholar
|
|
33
|
Ferrante CJ, Pinhal-Enfield G, Elson G,
Cronstein BN, Hasko G, Outram S and Leibovich SJ: The
adenosine-dependent angiogenic switch of macrophages to an M2-like
phenotype is independent of interleukin-4 receptor alpha (IL-4Rα)
signaling. Inflammation. 36:921–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zizzo G, Hilliard BA, Monestier M and
Cohen PL: Efficient clearance of early apoptotic cells by human
macrophages requires M2c polarization and MerTK induction. J
Immunol. 189:3508–3520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mosser DM and Edwards JP: Exploring the
full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Edwards JP, Zhang X, Frauwirth KA and
Mosser DM: Biochemical and functional characterization of three
activated macrophage populations. J Leukoc Biol. 80:1298–1307.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chhor V, Le Charpentier T, Lebon S, Oré
MV, Celador IL, Josserand J, Degos V, Jacotot E, Hagberg H, Sävman
K, et al: Characterization of phenotype markers and neuronotoxic
potential of polarised primary microglia in vitro. Brain Behav
Immun. 32:70–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Freilich RW, Woodbury ME and Ikezu T:
Integrated expression profiles of mRNA and miRNA in polarized
primary murine microglia. PLoS One. 8:e794162013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fenn AM, Henry CJ, Huang Y, Dugan A and
Godbout JP: Lipopolysaccharide-induced interleukin (IL)-4
receptor-α expression and corresponding sensitivity to the M2
promoting effects of IL-4 are impaired in microglia of aged mice.
Brain Behav Immun. 26:766–777. 2012. View Article : Google Scholar
|
|
40
|
Liu HC, Zheng MH, Du YL, Wang L, Kuang F,
Qin HY, Zhang BF and Han H: N9 microglial cells polarized by LPS
and IL4 show differential responses to secondary environmental
stimuli. Cell Immunol. 278:84–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Michelucci A, Heurtaux T, Grandbarbe L,
Morga E and Heuschling P: Characterization of the microglial
phenotype under specific pro-inflammatory and anti-inflammatory
conditions: Effects of oligomeric and fibrillar amyloid-beta. J
Neuroimmunol. 210:3–12. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Crane MJ, Daley JM, van Houtte O, Brancato
SK, Henry WJ Jr and Albina JE: The monocyte to macrophage
transition in the murine sterile wound. PLoS One. 9:e866602014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Italiani P, Mazza EM, Lucchesi D, Cifola
I, Gemelli C, Grande A, Battaglia C, Bicciato S and Boraschi D:
Transcriptomic profiling of the development of the inflammatory
response in human monocytes in vitro. PLoS One. 9:e876802014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Orecchioni M, Ghosheh Y, Pramod AB and Ley
K: Macrophage polarization: Different gene signatures in M1(LPS+)
vs. classically and M2(LPS-) vs. alternatively activated
macrophages. Front Immunol. 10:10842019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Watanabe S, Alexander M, Misharin AV and
Budinger GRS: The role of macrophages in the resolution of
inflammation. J Clin Invest. 129:2619–2628. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Atri C, Guerfali FZ and Laouini D: Role of
human macrophage polarization in inflammation during infectious
diseases. Int J Mol Sci. 19:18012018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
He C and Carter AB: The metabolic
prospective and redox regulation of macrophage polarization. J Clin
Cell Immunol. 6:3712015. View Article : Google Scholar
|
|
49
|
Bansal S, Barathi V, Iwata D and Agrawal
R: Experimental autoimmune uveitis and other animal models of
uveitis: An update. Indian J Ophthalmol. 63:211–218. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Meng X, Fang S, Zhang Z, Wang Y, You C,
Zhang J and Yan H: Preventive effect of chrysin on experimental
autoimmune uveitis triggered by injection of human IRBP peptide
1-20 in mice. Cell Mol Immunol. 14:702–711. 2017. View Article : Google Scholar
|
|
51
|
Bousquet E, Camelo S, Leroux Les Jardins
G, Goldenberg B, Naud MC, Besson-Lescure B, Lebreton L, Annat J,
Behar-Cohen F and de Kozak Y: Protective effect of intravitreal
administration of tresperimus, an immunosuppressive drug, on
experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci.
52:5414–5423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Haruta H, Ohguro N, Fujimoto M, Hohki S,
Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T and Naka T:
Blockade of interleukin-6 signaling suppresses not only th17 but
also interphotoreceptor retinoid binding protein-specific Th1 by
promoting regulatory T cells in experimental autoimmune
uveoretinitis. Investigative Invest Ophthalmol Vis Sci.
52:3264–3271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Luger D, Silver PB, Tang J, Cua D, Chen Z,
Iwakura Y, Bowman EP, Sgambellone NM, Chan CC and Caspi RR: Either
a Th17 or a Th1 effector response can drive autoimmunity:
Conditions of disease induction affect dominant effector category.
J Exp Med. 205:799–810. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhao J, Chen M and Xu H: Experimental
autoimmune uveoretinitis (EAU)-related tissue damage and
angiogenesis is reduced in CCL2-/-CX3CR1gfp/gfp mice. Invest
Ophthalmol Vis Sci. 55:7572–7582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen M, Copland DA, Zhao J, Liu J,
Forrester JV, Dick AD and Xu H: Persistent inflammation subverts
thrombospondin-1-induced regulation of retinal angiogenesis and is
driven by CCR2 ligation. Am J Pathol. 180:235–245. 2012. View Article : Google Scholar
|
|
56
|
Lipski DA, Dewispelaere R, Foucart V,
Caspers LE, Defrance M, Bruyns C and Willermain F: MHC class II
expression and potential antigen-presenting cells in the retina
during experimental autoimmune uveitis. J Neuroinflamm. 14:1362017.
View Article : Google Scholar
|
|
57
|
Miura-Takeda S, Tashiro-Yamaji J, Oku H,
Takahashi T, Shimizu T, Sugiyama T, Ikeda T, Kubota T and Yoshida
R: Experimental autoimmune uveoretinitis initiated by
non-phagocytic destruction of inner segments of photoreceptor cells
by Mac-1(+) mononuclear cells. Microbiol Immunol. 52:601–610. 2008.
View Article : Google Scholar
|
|
58
|
Niven J, Hoare J, McGowan D, Devarajan G,
Itohara S, Gannagé M, Teismann P and Crane I: S100B up-regulates
macrophage production of IL1β and CCL22 and influences severity of
retinal inflammation. PLoS One. 10:e1326882015. View Article : Google Scholar
|
|
59
|
Nguyen AM and Rao NA: Oxidative
photoreceptor cell damage in autoimmune uveitis. J Ophthalmic
Inflamm Infect. 1:7–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu GS, Lee TD, Moore RE and Rao NA:
Photoreceptor mitochondrial tyrosine nitration in experimental
uveitis. Invest Ophthalmol Vis Sci. 46:2271–2281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kimura A, Naka T, Nakahama T, Chinen I,
Masuda K, Nohara K, Fujii-Kuriyama Y and Kishimoto T: Aryl
hydrocarbon receptor in combination with Stat1 regulates
LPS-induced inflammatory responses. J Exp Med. 206:2027–2035. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Huang Y, He J, Liang H, Hu K, Jiang S,
Yang L, Mei S, Zhu X, Yu J, Kijlstra A, et al: Aryl hydrocarbon
receptor regulates apoptosis and inflammation in a murine model of
experimental autoimmune uveitis. Front Immunol. 9:17132018.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chackerian AA, Oldham ER, Murphy EE,
Schmitz J, Pflanz S and Kastelein RA: IL-1 receptor accessory
protein and ST2 comprise the IL-33 receptor complex. J Immunol.
179:2551–2555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kurowska-Stolarska M, Stolarski B, Kewin
P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B,
van Rooijen N, et al: IL-33 amplifies the polarization of
alternatively activated macrophages that contribute to airway
inflammation. J Immunol. 183:6469–6477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Barbour M, Allan D, Xu H, Pei C, Chen M,
Niedbala W, Fukada SY, Besnard AG, Alves-Filho JC, Tong X, et al:
IL-33 attenuates the development of experimental autoimmune
uveitis. Eur J Immunol. 44:3320–3329. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Qu R, Zhou M, Qiu Y, Peng Y, Yin X, Liu B,
Bi H, Gao Y and Guo D: Glucocorticoids improve the balance of M1/M2
macrophage polarization in experimental autoimmune uveitis through
the P38MAPK-MEF2C axis. Int Immunopharmacol. 120:1103922023.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tortorella C, Simone O, Piazzolla G,
Stella I and Antonaci S: Age-related impairment of GM-CSF-induced
signalling in neutrophils: Role of SHP-1 and SOCS proteins. Ageing
Res Rev. 6:81–93. 2007. View Article : Google Scholar
|
|
68
|
Jost MM, Ninci E, Meder B, Kempf C, Van
Royen N, Hua J, Berger B, Hoefer I, Modolell M and Buschmann I:
Divergent effects of GM-CSF and TGFbeta1 on bone marrow-derived
macrophage arginase-1 activity, MCP-1 expression, and matrix
metalloproteinase-12: A potential role during arteriogenesis. FASEB
J. 17:2281–2283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Chen M, Zhao J, Ali IHA, Marry S,
Augustine J, Bhuckory M, Lynch A, Kissenpfennig A and Xu H:
Cytokine signaling protein 3 deficiency in myeloid cells promotes
retinal degeneration and angiogenesis through arginase-1
up-regulation in experimental autoimmune uveoretinitis. Am J
Pathol. 188:1007–1020. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Benitez JT and Bouchard KR: Brain stem
auditory evoked response correlates in patients with
spinocerebellar lesions. Am J Otol. 7:183–187. 1986.PubMed/NCBI
|
|
71
|
Horstmann L, Schmid H, Heinen AP, Kurschus
FC, Dick HB and Joachim SC: Inflammatory demyelination induces glia
alterations and ganglion cell loss in the retina of an experimental
autoimmune encephalomyelitis model. J Neuroinflamm. 10:1202013.
View Article : Google Scholar
|
|
72
|
Cui Q, Yin Y and Benowitz LI: The role of
macrophages in optic nerve regeneration. Neuroscience.
158:1039–1048. 2009. View Article : Google Scholar
|
|
73
|
Starossom SC, Veremeyko T, Yung AWY,
Dukhinova M, Au C, Lau AY, Weiner HL and Ponomarev ED: Platelets
play differential role during the initiation and progression of
autoimmune neuroinflammation. Circ Res. 117:779–792. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Martinez FO and Gordon S: The M1 and M2
paradigm of macrophage activation: Time for reassessment.
F1000Prime Rep. 6:132014. View
Article : Google Scholar : PubMed/NCBI
|
|
75
|
McGeachy MJ: GM-CSF: The secret weapon in
the T(H)17 arsenal. Nat Immunol. 12:521–522. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ponomarev ED, Shriver LP, Maresz K,
Pedras-Vasconcelos J, Verthelyi D and Dittel BN: GM-CSF production
by autoreactive T cells is required for the activation of
microglial cells and the onset of experimental autoimmune
encephalomyelitis. J Immunol. 178:39–48. 2007. View Article : Google Scholar
|
|
77
|
Ponomarev ED, Shriver LP, Maresz K and
Dittel BN: Microglial cell activation and proliferation precedes
the onset of CNS autoimmunity. J Neurosci Res. 81:374–389. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ponomarev ED, Maresz K, Tan Y and Dittel
BN: CNS-derived interleukin-4 is essential for the regulation of
autoimmune inflammation and induces a state of alternative
activation in microglial cells. J Neurosci. 27:10714–10721. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang HL, Hassan MY, Zheng XY, Azimullah
S, Quezada HC, Amir N, Elwasila M, Mix E, Adem A and Zhu J:
Attenuated EAN in TNF-α deficient mice is associated with an
altered balance of M1/M2 macrophages. PLoS One. 7:e381572012.
View Article : Google Scholar
|
|
80
|
Kroenke MA, Carlson TJ, Andjelkovic AV and
Segal BM: IL-12- and IL-23-modulated T cells induce distinct types
of EAE based on histology, CNS chemokine profile, and response to
cytokine inhibition. J Exp Med. 205:1535–1541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ha Y, Liu H, Zhu S, Yi P, Liu W, Nathanson
J, Kayed R, Loucas B, Sun J, Frishman LJ, et al: Critical Role of
the CXCL10/C-X-C chemokine receptor 3 axis in promoting leukocyte
recruitment and neuronal injury during traumatic optic neuropathy
induced by optic nerve crush. Am J Pathol. 187:352–365. 2017.
View Article : Google Scholar :
|
|
82
|
Kwon MJ, Shin HY, Cui Y, Kim H, Thi AH,
Choi JY, Kim EY, Hwang DH and Kim BG: CCL2 mediates
neuron-macrophage interactions to drive proregenerative macrophage
activation following preconditioning injury. J Neurosci.
35:15934–15947. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Butti E, Bergami A, Recchia A, Brambilla
E, Del Carro U, Amadio S, Cattalini A, Esposito M, Stornaiuolo A,
Comi G, et al: IL4 gene delivery to the CNS recruits regulatory T
cells and induces clinical recovery in mouse models of multiple
sclerosis. Gene Ther. 15:504–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Georgiou T, Wen YT, Chang CH, Kolovos P,
Kalogerou M, Prokopiou E, Neokleous A, Huang CT and Tsai RK:
Neuroprotective effects of Omega-3 polyunsaturated fatty acids in a
rat model of anterior ischemic optic neuropathy. Invest Ophthalmol
Vis Sci. 58:1603–1611. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Locri F, Cammalleri M, Pini A, Dal Monte
M, Rusciano D and Bagnoli P: Further evidence on efficacy of diet
supplementation with fatty acids in ocular pathologies: Insights
from the EAE model of optic neuritis. Nutrients. 10:14472018.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sen HN and Nussenblatt RB: Sympathetic
ophthalmia: What have we learned? Am J Ophthalmol. 148:632–633.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Castiblanco CP and Adelman RA: Sympathetic
ophthalmia. Graefes Arch Clin Exp Ophthalmol. 247:289–302. 2009.
View Article : Google Scholar
|
|
88
|
Jakobiec FA, Marboe CC, Knowles DN II,
Iwamoto T, Harrison W, Chang S and Coleman DJ: Human sympathetic
ophthalmia. An analysis of the inflammatory infiltrate by
hybridoma-monoclonal antibodies, immunochemistry, and correlative
electron microscopy. Ophthalmology. 90:76–95. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Shah DN, Piacentini MA, Burnier MN, McLean
IW, Nussenblatt RB and Chan CC: Inflammatory cellular kinetics in
sympathetic ophthalmia a study of 29 traumatized (exciting) eyes.
Ocul Immunol Inflamm. 1:255–262. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Abu El-Asrar AM, Struyf S, Van den Broeck
C, Van Damme J, Opdenakker G, Geboes K and Kestelyn P: Expression
of chemokines and gelatinase B in sympathetic ophthalmia. Eye
(Lond). 21:649–657. 2007. View Article : Google Scholar
|
|
91
|
Aziz HA, Flynn HW Jr, Young RC, Davis JL
and Dubovy SR: Sympathetic ophthalmia: Clinicopathologic
correlation in a consecutive case series. Retina. 35:1696–1703.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chan CC, Nussenblatt RB, Fujikawa LS,
Palestine AG, Stevens G Jr, Parver LM, Luckenbach MW and Kuwabara
T: Sympathetic ophthalmia. Immunopathological findings.
Ophthalmology. 93:690–695. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Furusato E, Shen D, Cao X, Furusato B,
Nussenblatt RB, Rushing EJ and Chan CC: Inflammatory cytokine and
chemokine expression in sympathetic ophthalmia: A pilot study.
Histol Histopathol. 26:1145–1151. 2011.PubMed/NCBI
|
|
94
|
Marak GE Jr: Recent advances in
sympathetic ophthalmia. Surv Ophthalmol. 24:141–156. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ben M'Barek K and Monville C: Cell therapy
for retinal dystrophies: From cell suspension formulation to
complex retinal tissue bioengineering. Stem Cells Int.
2019:45689792019.PubMed/NCBI
|
|
96
|
Athanasiou D, Aguila M, Bellingham J, Li
W, McCulley C, Reeves PJ and Cheetham ME: The molecular and
cellular basis of rhodopsin retinitis pigmentosa reveals potential
strategies for therapy. Prog Retin Eye Res. 62:1–23. 2018.
View Article : Google Scholar :
|
|
97
|
Kyger M, Worley A and Adamus G: Autoimmune
responses against photoreceptor antigens during retinal
degeneration and their role in macrophage recruitment into retinas
of RCS rats. J Neuroimmunol. 254:91–100. 2013. View Article : Google Scholar :
|
|
98
|
Sevenich L: Brain-resident microglia and
blood-borne macrophages orchestrate central nervous system
inflammation in neurodegenerative disorders and brain cancer. Front
Immunol. 9:6972018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Xu H, Chen M and Forrester JV:
Para-inflammation in the aging retina. Prog Retin Eye Res.
28:348–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Wohleb ES: Neuron-microglia interactions
in mental health disorders: 'For better, and for worse'. Front
Immunol. 7:5442016. View Article : Google Scholar
|
|
101
|
Edholm ES, Rhoo KH and Robert J:
Evolutionary aspects of macrophages polarization. Results Probl
Cell Differ. 62:3–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Neves J, Zhu J, Sousa-Victor P, Konjikusic
M, Riley R, Chew S, Qi Y, Jasper H and Lamba DA: Immune modulation
by MANF promotes tissue repair and regenerative success in the
retina. Science. 353:aaf36462016. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Xie J, Li Y, Dai J, He Y, Sun D, Dai C, Xu
H and Yin ZQ: Olfactory ensheathing cells grafted into the retina
of RCS rats suppress inflammation by down-regulating the JAK/STAT
pathway. Front Cell Neurosci. 13:3412019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Olivares-González L, Velasco S, Gallego I,
Esteban-Medina M, Puras G, Loucera C, Martínez-Romero A,
Peña-Chilet M, Pedraz JL and Rodrigo R: An SPM-enriched marine oil
supplement shifted microglia polarization toward M2, ameliorating
retinal degeneration in rd10 mice. Antioxidants (Basel). 12:982022.
View Article : Google Scholar
|
|
105
|
Quigley HA, Nickells RW, Kerrigan LA,
Pease ME, Thibault DJ and Zack DJ: Retinal ganglion cell death in
experimental glaucoma and after axotomy occurs by apoptosis. Invest
Ophthalmol Vis Sci. 36:774–786. 1995.PubMed/NCBI
|
|
106
|
Levkovitch-Verbin H, Dardik R, Vander S,
Nisgav Y, Kalev-Landoy M and Melamed S: Experimental glaucoma and
optic nerve transection induce simultaneous upregulation of
proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci.
47:2491–2497. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Prilloff S, Henrich-Noack P and Sabel BA:
Recovery of axonal transport after partial optic nerve damage is
associated with secondary retinal ganglion cell death in vivo.
Invest Ophthalmol Vis Sci. 53:1460–1466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Levkovitch-Verbin H, Quigley HA, Martin
KRG, Zack DJ, Pease ME and Valenta DF: A model to study differences
between primary and secondary degeneration of retinal ganglion
cells in rats by partial optic nerve transection. Invest Ophthalmol
Vis Sci. 44:3388–3393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Levkovitch-Verbin H, Quigley HA,
Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D and Pease ME: Optic
nerve transection in monkeys may result in secondary degeneration
of retinal ganglion cells. Invest Ophthalmol Vis Sci. 42:975–982.
2001.PubMed/NCBI
|
|
110
|
Yoles E and Schwartz M: Degeneration of
spared axons following partial white matter lesion: Implications
for optic nerve neuropathies. Exp Neurol. 153:1–7. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Li HY, Huang M, Luo QY, Hong X,
Ramakrishna S and So KF: Lycium barbarum (wolfberry) increases
retinal ganglion cell survival and affects both
microglia/macrophage polarization and autophagy after rat partial
optic nerve transection. Cell Transplant. 28:607–618. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Wada Y, Nakamachi T, Endo K, Seki T,
Ohtaki H, Tsuchikawa D, Hori M, Tsuchida M, Yoshikawa A, Matkovits
A, et al: PACAP attenuates NMDA-induced retinal damage in
association with modulation of the microglia/macrophage status into
an acquired deactivation subtype. J Mol Neurosci. 51:493–502. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Schwartz M: Macrophages and microglia in
central nervous system injury: Are they helpful or harmful? J Cereb
Blood Flow Metab. 23:385–394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Hayreh SS: Ischemic optic neuropathy. Prog
Retin Eye Res. 28:34–62. 2009. View Article : Google Scholar
|
|
115
|
Salgado C, Vilson F, Miller NR and
Bernstein SL: Cellular inflammation in nonarteritic anterior
ischemic optic neuropathy and its primate model. Arch Ophthalmol.
129:1583–1591. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhang C, Guo Y, Miller NR and Bernstein
SL: Optic nerve infarction and post-ischemic inflammation in the
rodent model of anterior ischemic optic neuropathy (rAION). Brain
Res. 1264:67–75. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Nicholson JD, Leiba H and Goldenberg-Cohen
N: Translational preclinical research may lead to improved medical
management of non-arteritic anterior ischemic optic neuropathy.
Front Neurol. 5:1222014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Hayreh SS and Zimmerman MB: Nonarteritic
anterior ischemic optic neuropathy: Natural history of visual
outcome. Ophthalmology. 115:298–305.e2. 2008. View Article : Google Scholar
|
|
119
|
Bernstein SL, Johnson MA and Miller NR:
Nonarteritic anterior ischemic optic neuropathy (NAION) and its
experimental models. Prog Retin Eye Res. 30:167–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yin Y, Cui Q, Li Y, Irwin N, Fischer D,
Harvey AR and Benowitz LI: Macrophage-derived factors stimulate
optic nerve regeneration. J Neurosci. 23:2284–2293. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Orihuela R, McPherson CA and Harry GJ:
Microglial M1/M2 polarization and metabolic states. Brit J
Pharmacol. 173:649–665. 2016. View Article : Google Scholar
|
|
122
|
Wen YT, Huang TL, Huang SP, Chang CH and
Tsai RK: Early applications of granulocyte colony-stimulating
factor (G-CSF) can stabilize the blood-optic-nerve barrier and
ameliorate inflammation in a rat model of anterior ischemic optic
neuropathy (rAION). Dis Model Mech. 9:1193–1202. 2016.PubMed/NCBI
|
|
123
|
Desai TD, Wen YT, Daddam JR, Cheng F, Chen
CC, Pan CL, Lin KL and Tsai RK: Long term therapeutic effects of
icariin-loaded PLGA microspheres in an experimental model of optic
nerve ischemia via modulation of CEBP-β/G-CSF/noncanonical NF-κB
axis. Bioeng Transl Med. 7:e102892022. View Article : Google Scholar
|
|
124
|
Nguyen Ngo Le MA, Wen YT, Ho YC, Kapupara
K and Tsai RK: Therapeutic effects of puerarin against anterior
ischemic optic neuropathy through antiapoptotic and
anti-inflammatory actions. Invest Ophthalmol Vis Sci. 60:3481–3491.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Arranz A, Doxaki C, Vergadi E, Martinez de
la Torre Y, Vaporidi K, Lagoudaki ED, Ieronymaki E, Androulidaki A,
Venihaki M, Margioris AN, et al: Akt1 and Akt2 protein kinases
differentially contribute to macrophage polarization. Proc Natl
Acad Sci USA. 109:9517–9522. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Friedlander M: Fibrosis and diseases of
the eye. J Clin Invest. 117:576–586. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Wynn TA: Common and unique mechanisms
regulate fibrosis in various fibroproliferative diseases. J Clin
Invest. 117:524–529. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wermuth PJ and Jimenez SA: The
significance of macrophage polarization subtypes for animal models
of tissue fibrosis and human fibrotic diseases. Clin Transl Med.
4:22015. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Pastor JC, de la Rúa ER and Martin F:
Proliferative vitreoretinopathy: Risk factors and pathobiology.
Prog Retin Eye Res. 21:127–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Cordeiro MF, Schultz GS, Ali RR,
Bhattacharya SS and Khaw PT: Molecular therapy in ocular wound
healing. Br J Ophthalmol. 83:1219–1224. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ
and Hinton DR: In vivo models of proliferative vitreoretinopathy.
Nat Protoc. 2:67–77. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Esser P, Heimann K and Wiedemann P:
Macrophages in proliferative vitreoretinopathy and proliferative
diabetic retinopathy: Differentiation of subpopulations. Br J
Ophthalmol. 77:731–733. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Martin F, Pastor JC, De La Rúa ER,
Mayo-Iscar A, García-Arumí J, Martínez V, Fernández N and Saornil
MA: Proliferative vitreoretinopathy: Cytologic findings in vitreous
samples. Ophthalmic Res. 35:232–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Garweg JG, Tappeiner C and Halberstadt M:
Pathophysiology of proliferative vitreoretinopathy in retinal
detachment. Surv Ophthalmol. 58:321–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Biswas SK and Mantovani A: Macrophage
plasticity and interaction with lymphocyte subsets: Cancer as a
paradigm. Nat Immunol. 11:889–896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wong CW, Cheung N, Ho C, Barathi V, Storm
G and Wong TT: Characterisation of the inflammatory cytokine and
growth factor profile in a rabbit model of proliferative
vitreoretinopathy. Sci Rep. 9:154192019. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Ishikawa K, Kannan R and Hinton DR:
Molecular mechanisms of subretinal fibrosis in age-related macular
degeneration. Exp Eye Res. 142:19–25. 2016. View Article : Google Scholar
|
|
139
|
Song Y, Liao M, Zhao X, Han H, Dong X,
Wang X, Du M and Yan H: Vitreous M2 macrophage-derived
microparticles promote RPE cell proliferation and migration in
traumatic proliferative vitreoretinopathy. Invest Ophthalmol Vis
Sci. 62:262021. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Kobayashi Y, Yoshida S, Nakama T, Zhou Y,
Ishikawa K, Arita R, Nakao S, Miyazaki M, Sassa Y, Oshima Y, et al:
Overexpression of CD163 in vitreous and fibrovascular membranes of
patients with proliferative diabetic retinopathy: possible
involvement of periostin. Br J Ophthalmol. 99:451–456. 2015.
View Article : Google Scholar
|
|
141
|
Zhang J, Zhou Q, Yuan G, Dong M and Shi W:
Notch signaling regulates M2 type macrophage polarization during
the development of proliferative vitreoretinopathy. Cell Immunol.
298:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Lim LS, Mitchell P, Seddon JM, Holz FG and
Wong TY: Age-related macular degeneration. Lancet. 379:1728–1738.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Greaves NS, Ashcroft KJ, Baguneid M and
Bayat A: Current understanding of molecular and cellular mechanisms
in fibroplasia and angiogenesis during acute wound healing. J
Dermatol Sci. 72:206–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Kent D and Sheridan C: Choroidal
neovascularization: A wound healing perspective. Mol Vis.
9:747–755. 2003.
|
|
145
|
Cherepanoff S, McMenamin P, Gillies MC,
Kettle E and Sarks SH: Bruch's membrane and choroidal macrophages
in early and advanced age-related macular degeneration. Br J
Ophthalmol. 94:918–925. 2010. View Article : Google Scholar
|
|
146
|
Bo Q, Shen M, Xiao M, Liang J, Zhai Y, Zhu
H, Jiang M, Wang F, Luo X and Sun X: 3-Methyladenine alleviates
experimental subretinal fibrosis by inhibiting macrophages and M2
polarization through the PI3K/Akt pathway. J Ocul Pharmacol Ther.
36:618–628. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
He L and Marneros AG: Macrophages are
essential for the early wound healing response and the formation of
a fibrovascular scar. Am J Pathol. 182:2407–2417. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Cao X, Shen D, Patel MM, Tuo J, Johnson
TM, Olsen TW and Chan CC: Macrophage polarization in the maculae of
age-related macular degeneration: A pilot study. Pathol Int.
61:528–535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Lai K, Li Y, Li L, Gong Y, Huang C, Zhang
Y, Cheng L, Xu F, Zhao H, Li C, et al: Intravitreal injection of
triptolide attenuates subretinal fibrosis in laser-induced murine
model. Phytomedicine. 93:1537472021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Mehla K and Singh PK: Metabolic regulation
of macrophage polarization in cancer. Trends Cancer. 5:822–834.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Egan KM, Seddon JM, Glynn RJ, Gragoudas ES
and Albert DM: Epidemiologic aspects of uveal melanoma. Surv
Ophthalmol. 32:239–251. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Johnson DB and Daniels AB: Continued poor
survival in metastatic uveal melanoma: Implications for molecular
prognostication, surveillance imaging, adjuvant therapy, and
clinical trials. JAMA Ophthalmol. 136:986–988. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hood JL: The association of exosomes with
lymph nodes. Semin Cell Dev Biol. 67:29–38. 2017. View Article : Google Scholar
|
|
154
|
Bardi GT, Smith MA and Hood JL: Melanoma
exosomes promote mixed M1 and M2 macrophage polarization. Cytokine.
105:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Delwar ZM, Kuo Y, Wen YH, Rennie PS and
Jia W: Oncolytic virotherapy blockade by microglia and macrophages
requires STAT1/3. Cancer Res. 78:718–730. 2018. View Article : Google Scholar
|
|
156
|
Zhou D, Huang C, Lin Z, Zhan S, Kong L,
Fang C and Li J: Macrophage polarization and function with emphasis
on the evolving roles of coordinated regulation of cellular
signaling pathways. Cell Signal. 26:192–197. 2014. View Article : Google Scholar
|
|
157
|
Liu S, Zhang J, Fang S, Zhang Q, Zhu G,
Tian Y, Zhao M and Liu F: Macrophage polarization contributes to
the efficacy of an oncolytic HSV-1 targeting human uveal melanoma
in a murine xenograft model. Exp Eye Res. 202:1082852021.
View Article : Google Scholar
|
|
158
|
Spiller KL, Anfang RR, Spiller KJ, Ng J,
Nakazawa KR, Daulton JW and Vunjak-Novakovic G: The role of
macrophage phenotype in vascularization of tissue engineering
scaffolds. Biomaterials. 35:4477–4488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Jetten N, Verbruggen S, Gijbels MJ, Post
MJ, De Winther MPJ and Donners MMPC: Anti-inflammatory M2, but not
pro-inflammatory M1 macrophages promote angiogenesis in vivo.
Angiogenesis. 17:109–118. 2014. View Article : Google Scholar
|
|
160
|
Cheung N, Mitchell P and Wong TY: Diabetic
retinopathy. Lancet. 376:124–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Jenkins AJ, Joglekar MV, Hardikar AA,
Keech AC, O'Neal DN and Januszewski AS: Biomarkers in diabetic
retinopathy. Rev Diabet Stud. 12:159–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Wu JH, Li YN, Chen AQ, Hong CD, Zhang CL,
Wang HL, Zhou YF, Li PC, Wang Y, Mao L, et al: Inhibition of
Sema4D/PlexinB1 signaling alleviates vascular dysfunction in
diabetic retinopathy. EMBO Mol Med. 12:e101542020. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Madonna R, Balistreri CR, Geng YJ and De
Caterina R: Diabetic microangiopathy: Pathogenetic insights and
novel therapeutic approaches. Vasc Pharmacol. 90:1–7. 2017.
View Article : Google Scholar
|
|
164
|
Chen C, Wu S, Hong Z, Chen X, Shan X,
Fischbach S and Xiao X: Chronic hyperglycemia regulates microglia
polarization through ERK5. Aging (Albany NY). 11:697–706. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Chen T, Zhu W, Wang C, Dong X, Yu F, Su Y,
Huang J, Huo L and Wan P: ALKBH5-mediated m6A
modification of A20 regulates microglia polarization in diabetic
retinopathy. Front Immunol. 13:8139792022. View Article : Google Scholar
|
|
166
|
Yao Y, Li J, Zhou Y, Wang S, Zhang Z,
Jiang Q and Li K: Macrophage/microglia polarization for the
treatment of diabetic retinopathy. Front Endocrinol (Lausanne).
14:12762252023. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Tang L, Zhang C, Lu L, Tian H, Liu K, Luo
D, Qiu Q, Xu GT and Zhang J: Melatonin maintains inner
blood-retinal barrier by regulating microglia via inhibition of
PI3K/Akt/Stat3/NF-κB signaling pathways in experimental diabetic
retinopathy. Front Immunol. 13:8316602022. View Article : Google Scholar
|
|
168
|
Fang M, Wan W, Li Q, Wan W, Long Y, Liu H
and Yang X: Asiatic acid attenuates diabetic retinopathy through
TLR4/MyD88/NF-κB p65 mediated modulation of microglia polarization.
Life Sci. 277:1195672021. View Article : Google Scholar
|
|
169
|
Good WV, Hardy RJ, Dobson V, Palmer EA,
Phelps DL, Quintos M and Tung B; Early Treatment for Retinopathy of
Prematurity Cooperative Group: The incidence and course of
retinopathy of prematurity: Findings from the early treatment for
retinopathy of prematurity study. Pediatrics. 116:15–23. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Dogra MR, Katoch D and Dogra M: An update
on retinopathy of prematurity (ROP). Indian J Pediatr. 84:930–936.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Dhawan A, Dogra M, Vinekar A, Gupta A and
Dutta S: Structural sequelae and refractive outcome after
successful laser treatment for threshold retinopathy of
prematurity. J Pediatr Ophthalmol Strabismus. 45:356–361. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Katoch D, Sanghi G, Dogra MR, Beke N and
Gupta A: Structural sequelae and refractive outcome 1 year after
laser treatment for type 1 prethreshold retinopathy of prematurity
in Asian Indian eyes. Indian J Ophthalmol. 59:423–426. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Lee J, Kim KE, Choi DK, Jang JY, Jung JJ,
Kiyonari H, Shioi G, Chang W, Suda T, Mochizuki N, et al:
Angiopoietin-1 guides directional angiogenesis through integrin
αvβ5 signaling for recovery of ischemic retinopathy. Sci Transl
Med. 5:203ra1272013. View Article : Google Scholar
|
|
174
|
Ma J, Mehta M, Lam G, Cyr D, Ng TF, Hirose
T, Tawansy KA, Taylor AW and Lashkari K: Influence of subretinal
fluid in advanced stage retinopathy of prematurity on proangiogenic
response and cell proliferation. Mol Vis. 20:881–893.
2014.PubMed/NCBI
|
|
175
|
Li J, Yu S, Lu X, Cui K, Tang X, Xu Y and
Liang X: The phase changes of M1/M2 phenotype of
microglia/macrophage following oxygen-induced retinopathy in mice.
Inflamm Res. 70:183–192. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Outtz HH, Tattersall IW, Kofler NM,
Steinbach N and Kitajewski J: Notch1 controls macrophage
recruitment and Notch signaling is activated at sites of
endothelial cell anastomosis during retinal angiogenesis in mice.
Blood. 118:3436–3439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Marchetti V, Yanes O, Aguilar E, Wang M,
Friedlander D, Moreno S, Storm K, Zhan M, Naccache S, Nemerow G, et
al: Differential macrophage polarization promotes tissue remodeling
and repair in a model of ischemic retinopathy. Sci Rep. 1:762011.
View Article : Google Scholar :
|
|
178
|
Sun X, Ma L, Li X, Wang J, Li Y and Huang
Z: Ferulic acid alleviates retinal neovascularization by modulating
microglia/macrophage polarization through the ROS/NF-κB axis. Front
Immunol. 13:9767292022. View Article : Google Scholar
|
|
179
|
Sui A, Chen X, Demetriades AM, Shen J, Cai
Y, Yao Y, Yao Y, Zhu Y, Shen X and Xie B: Inhibiting NF-κB
signaling activation reduces retinal neovascularization by
promoting a polarization shift in macrophages. Invest Ophthalmol
Vis Sci. 61:42020. View Article : Google Scholar
|
|
180
|
Zhu Y, Tan W, Demetriades AM, Cai Y, Gao
Y, Sui A, Lu Q, Shen X, Jiang C, Xie B and Sun X: Interleukin-17A
neutralization alleviated ocular neovascularization by promoting M2
and mitigating M1 macrophage polarization. Immunology. 147:414–428.
2016. View Article : Google Scholar :
|
|
181
|
Gao S, Li C, Zhu Y, Wang Y, Sui A, Zhong
Y, Xie B and Shen X: PEDF mediates pathological neovascularization
by regulating macrophage recruitment and polarization in the mouse
model of oxygen-induced retinopathy. Sci Rep. 7:428462017.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Zhou Y, Yoshida S, Nakao S, Yoshimura T,
Kobayashi Y, Nakama T, Kubo Y, Miyawaki K, Yamaguchi M, Ishikawa K,
et al: M2 macrophages enhance pathological neovascularization in
the mouse model of oxygen-induced retinopathy. Invest Ophthalmol
Vis Sci. 56:4767–4777. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Ritter MR, Banin E, Moreno SK, Aguilar E,
Dorrell MI and Friedlander M: Myeloid progenitors differentiate
into microglia and promote vascular repair in a model of ischemic
retinopathy. J Clin Invest. 116:3266–3276. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Fine SL, Berger JW, Maguire MG and Ho AC:
Age-related macular degeneration. New Engl J Med. 342:483–492.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Rosenfeld PJ, Shapiro H, Tuomi L, Webster
M, Elledge J and Blodi B; MARINA and ANCHOR Study Groups:
Characteristics of patients losing vision after 2 years of monthly
dosing in the phase III ranibizumab clinical trials. Ophthalmology.
118:523–530. 2011. View Article : Google Scholar
|
|
186
|
CATT Research Group; Martin DF, Maguire
MG, Ying GS, Grunwald JE, Fine SL and Jaffe GJ: Ranibizumab and
bevacizumab for neovascular age-related macular degeneration. New
Engl J Med. 364:1897–1908. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Takeda A, Baffi JZ, Kleinman ME, Cho WG,
Nozaki M, Yamada K, Kaneko H, Albuquerque RJ, Dridi S, Saito K, et
al: CCR3 is a target for age-related macular degeneration diagnosis
and therapy. Nature. 460:225–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Rosenfeld PJ, Brown DM, Heier JS, Boyer
DS, Kaiser PK, Chung CY and Kim RY; MARINA Study Group: Ranibizumab
for neovascular age-related macular degeneration. N Engl J Med.
355:1419–1431. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Brown DM, Kaiser PK, Michels M, Soubrane
G, Heier JS, Kim RY, Sy JP and Schneider S; ANCHOR Study Group:
Ranibizumab versus verteporfin for neovascular age-related macular
degeneration. N Engl J Med. 355:1432–1444. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Grisanti S and Tatar O: The role of
vascular endothelial growth factor and other endogenous
interplayers in age-related macular degeneration. Prog Retin Eye
Res. 27:372–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Zarbin MA: Current concepts in the
pathogenesis of age-related macular degeneration. Arch Ophthalmol.
122:598–614. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
He L and Marneros AG: Doxycycline inhibits
polarization of macrophages to the proangiogenic M2-type and
subsequent neovascularization. J Biol Chem. 289:8019–8028. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Nakamura R, Sene A, Santeford A, Gdoura A,
Kubota S, Zapata N and Apte RS: IL10-driven STAT3 signalling in
senescent macrophages promotes pathological eye angiogenesis. Nat
Commun. 6:78472015. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Yang Y, Liu F, Tang M, Yuan M, Hu A, Zhan
Z, Li Z, Li J, Ding X and Lu L: Macrophage polarization in
experimental and clinical choroidal neovascularization. Sci Rep.
6:309332016. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Wang C, Zhang R, Zhang Q, Jin H, Wei C, Wu
C, Mei L, Liu Y and Zhang P: Cytokine profiles and the effect of
intravitreal aflibercept treatment on experimental choroidal
neovascularization. Ophthalmic Res. 65:68–76. 2022. View Article : Google Scholar
|
|
196
|
Manthey CL, Moore BA, Chen Y, Loza MJ, Yao
X, Liu H, Belkowski SM, Raymond-Parks H, Dunford PJ, Leon F, et al:
The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced
inflammatory macrophage recruitment to the intestinal mucosa and
suppressed murine T cell mediated colitis. PLoS One.
14:e2239182019. View Article : Google Scholar
|
|
197
|
Braza MS, Conde P, Garcia M, Cortegano I,
Brahmachary M, Pothula V, Fay F, Boros P, Werner SA, Ginhoux F, et
al: Neutrophil derived CSF1 induces macrophage polarization and
promotes transplantation tolerance. Am J Transplant. 18:1247–1255.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Zhou Y, Zeng J, Tu Y, Li L, Du S, Zhu L,
Cang X, Lu J, Zhu M and Liu X: CSF1/CSF1R-mediated crosstalk
between choroidal vascular endothelial cells and macrophages
promotes choroidal neovascularization. Invest Ophthalmol Vis Sci.
62:372021. View Article : Google Scholar
|
|
199
|
Zhang P, Lu B, Zhang Q, Xu F, Zhang R,
Wang C, Liu Y, Wei C and Mei L: LncRNA NEAT1 sponges MiRNA-148a-3p
to suppress choroidal neovascularization and M2 macrophage
polarization. Mol Immunol. 127:212–222. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Zandi S, Nakao S, Chun KH, Fiorina P, Sun
D, Arita R, Zhao M, Kim E, Schueller O, Campbell S, et al:
ROCK-isoform-specific polarization of macrophages associated with
age-related macular degeneration. Cell Rep. 10:1173–1186. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Xu Y, Cui K, Li J, Tang X, Lin J, Lu X,
Huang R, Yang B, Shi Y, Ye D, et al: Melatonin attenuates choroidal
neovascularization by regulating macrophage/microglia polarization
via inhibition of RhoA/ROCK signaling pathway. J Pineal Res.
69:e126602020. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Zhao S, Lu L, Liu Q, Chen J, Yuan Q, Qiu S
and Wang X: MiR-505 promotes M2 polarization in choroidal
neovascularization model mice by targeting transmembrane protein
229B. Scand J Immunol. 90:e128322019. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Gao L, Jiang W, Liu H, Chen Z and Lin Y:
Receptor-selective interleukin-4 mutein attenuates laser-induced
choroidal neovascularization through the regulation of macrophage
polarization in mice. Exp Ther Med. 22:13672021. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Liu Z, Mao X, Yang Q, Zhang X, Xu J, Ma Q,
Zhou Y, Da Q, Cai Y, Sopeyin A, et al: Suppression of myeloid
PFKFB3-driven glycolysis protects mice from choroidal
neovascularization. Br J Pharmacol. 179:5109–5131. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Cheng Y, Cheng T and Qu Y: TIMP-3
suppression induces choroidal neovascularization by moderating the
polarization of macrophages in age-related macular degeneration.
Mol Immunol. 106:119–126. 2019. View Article : Google Scholar
|
|
206
|
Lai K, Gong Y, Zhao W, Li L, Huang C, Xu
F, Zhong X and Jin C: Triptolide attenuates laser-induced choroidal
neovascularization via M2 macrophage in a mouse model. Biomed
Pharmacother. 129:1103122020. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
